Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-04 Sale | 2023-11-08 4:16 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 435 | $0.88846 | $386 | 22,949 (Direct) | View |
| 2023-07-06 Sale | 2023-07-19 4:07 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 106 | $1.47 | $156 | 23,384 (Direct) | View |
| 2023-06-30 Purchase | 2023-07-06 4:16 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 17,702 | $1.52 | $26,907 | 23,490 (Direct) | View |
| 2023-03-31 Sale | 2023-07-06 4:16 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 303 | $2.4625 | $746 | 23,490 (Direct) | View |
| 2023-01-24 Sale | 2023-03-07 4:11 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 418 | $8.8703 | $3,708 | 6,091 (Direct) | View |
| 2022-11-28 Sale | 2022-12-20 4:35 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 372,113 | $0.16914 | $62,938 | 325,404 (Direct) | View |
| 2022-11-04 Sale | 2022-11-10 4:10 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 8,393 | $0.27247 | $2,287 | 332,761 (Direct) | View |
| 2022-10-04 Sale | 2022-10-06 5:29 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS CFO | 8,293 | $0.28085 | $2,329 | 338,670 (Direct) | View |
| 2022-09-06 Sale | 2022-09-12 4:05 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,828 | $0.39 | $1,883 | 346,963 (Direct) | View |
| 2022-08-05 Sale | 2022-08-11 4:30 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,728 | $0.47 | $2,222 | 351,791 (Direct) | View |
| 2022-08-05 Sale | 2022-08-11 4:15 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 11,674 | $0.47 | $5,487 | 773,098 (Direct) | View |
| 2022-07-01 Sale | 2022-07-06 4:08 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,630 | $0.55 | $2,547 | 356,519 (Direct) | View |
| 2022-07-01 Sale | 2022-07-06 4:03 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 11,442 | $0.55 | $6,293 | 784,772 (Direct) | View |
| 2022-06-01 Sale | 2022-06-06 4:58 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 11,309 | $0.95239 | $10,771 | 796,214 (Direct) | View |
| 2022-06-01 Sale | 2022-06-06 4:49 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,478 | $0.96 | $4,299 | 361,149 (Direct) | View |
| 2022-05-31 Purchase | 2022-06-01 2:18 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 20,000 | $0.92112 | $18,422 | 365,627 (Direct) | View |
| 2022-05-05 Sale | 2022-05-12 4:13 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 11,417 | $0.77 | $8,791 | 807,523 (Direct) | View |
| 2022-05-05 Sale | 2022-05-12 4:05 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,529 | $0.77 | $3,487 | 345,627 (Direct) | View |
| 2022-04-01 Sale | 2022-04-08 4:27 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 5,038 | $1.13 | $5,693 | 350,156 (Direct) | View |
| 2022-04-01 Sale | 2022-04-08 4:12 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 11,063 | $1.13 | $12,501 | 818,940 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 4:15 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS CFO | 3,658 | $1.06 | $3,877 | 355,194 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 4:08 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 6,538 | $1.06 | $6,930 | 830,003 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:32 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 8,324 | $1.22 | $10,155 | 836,541 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:22 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 3,684 | $1.22 | $4,494 | 358,852 (Direct) | View |
| 2022-01-04 Sale | 2022-01-28 4:58 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 7,150 | $1.79 | $12,799 | 844,865 (Direct) | View |
| 2022-01-04 Sale | 2022-01-28 4:46 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 3,171 | $1.78 | $5,644 | 362,536 (Direct) | View |
| 2021-12-02 Sale | 2021-12-09 4:22 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 13,427 | $1.83 | $24,571 | 852,015 (Direct) | View |
| 2021-12-02 Sale | 2021-12-09 4:17 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,304 | $1.827 | $7,863 | 365,707 (Direct) | View |
| 2021-11-18 Purchase | 2021-11-18 4:32 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 20,000 | $2.02 | $40,400 | 370,011 (Direct) | View |
| 2021-11-02 Sale | 2021-11-16 4:18 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 13,505 | $2.69 | $36,328 | 865,442 (Direct) | View |
| 2021-11-02 Sale | 2021-11-16 4:14 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,320 | $2.69 | $11,621 | 350,011 (Direct) | View |
| 2021-10-01 Sale | 2021-10-12 7:40 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 3,660 | $2.76 | $10,102 | 354,331 (Direct) | View |
| 2021-10-01 Sale | 2021-10-12 7:35 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 12,565 | $2.77 | $34,805 | 878,947 (Direct) | View |
| 2021-09-10 Sale | 2021-09-17 7:07 pm | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 294,494 | $2.89 | $851,088 | 891,512 (Direct) | View |
| 2021-09-10 Sale | 2021-09-17 6:51 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 48,366 | $2.89 | $139,778 | 357,991 (Direct) | View |
| 2021-09-10 Sale | 2021-09-17 6:37 pm | ReShape Lifesciences Inc. | RSLS | GLADNEY DAN W Director | 200,000 | $2.99 | $598,000 | 283,922 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-01-16 6:11 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | Schneid Yair 10% Owner | 0 | $0 | 2,461,000 (Direct) | View |
| 2022-11-17 Option Award | 2022-12-20 4:35 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 364,756 | $0 | 325,404 (Direct) | View |
Ownership | 2022-08-26 4:20 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | Hickey Paul F. President and CEO | 0 | $0 | 0 (Direct) | View |
| 2021-07-22 Option Award | 2021-09-17 7:07 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | Bandy Barton P. President and CEO | 1,186,006 | $0 | 891,512 (Direct) | View |
| 2021-07-22 Option Award | 2021-09-17 6:51 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 372,744 | $0 | 357,991 (Direct) | View |
| 2021-07-22 Option Award | 2021-09-17 6:37 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | GLADNEY DAN W Director | 483,922 | $0 | 283,922 (Direct) | View |
| 2021-07-22 Option Award | 2021-09-17 6:25 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | BLACKFORD GARY Director | 253,429 | $0 | 253,429 (Direct) | View |
| 2021-07-22 Option Award | 2021-09-17 6:18 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | MINOCHERHOMJEE ARDA PHD Director | 253,429 | $0 | 253,429 (Direct) | View |
| 2021-07-22 Option Award | 2021-09-17 6:07 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | McDougal Lori Courtney Director | 253,429 | $0 | 253,429 (Direct) | View |